Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (4): 128-132.doi: 10.6040/j.issn.1671-7554.0.2021.1011
TIAN Min, CAO Lili, SONG Chengyuan
CLC Number:
| [1] Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference [J]. Arch Neurol, 1988, 45(5): 575-578. [2] Orraca M, Morejón G, Cabrera N, et al. Neurofibromatosis 1 prevalence in children aged 9-11 years, Pinar del Rio Province, Cuba [J]. MEDICC Rev, 2014, 16(3-4): 22-26. [3] Kallionpaa RA, Uusitalo E, Leppävirta J, et al. Prevalence of neurofibromatosis type 1 in the Finnish population [J]. Genet Med, 2018, 20(9): 1082-1086. [4] Lammert M, Friedman JM, Kluwe L, et al. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment [J]. Arch Dermatol, 2005, 141(1): 71-74. [5] Brosius S. A history of von recklinghausens NF1 [J]. J Hist Neurosci, 2010, 19(4): 333-348. [6] Bergoug M, Doudeau M, Godin F, et al. Neurofibromin structure, functions and regulation [J]. Cells, 2020, 9(11): 2365-2398. [7] Dunning-Davies BM, Parker APJ. Annual review of children with neurofibromatosis type 1 [J]. Arch Dis Child Educ Pract Ed, 2016, 101(2): 102-111. [8] Nemethova M, Bolcekova A, Ilencikova D, et al. Thirty-nine novel neurofibromatosis 1(NF1)gene mutations identified in Slovak patients [J]. Ann Hum Genet, 2013, 77(5): 364-379. [9] Bata BM, Hodge DO, Mohney BG. Neurofibromatosis type 1: a population-based study [J]. J Pediatr Ophthalmol Strabismus, 2019, 56(4): 243-247. [10] Wallis D, Li K, Lui H, et al. Neurofibromin(NF1)genetic variant structure-function analyses using a full-length mouse cDNA [J]. Hum Mutat, 2018, 39(6): 816-821. [11] Trevisson E, Morbidoni V, Forzan M, et al. The Arg1038Gly missense variant in the NF1 gene causes a mild phenotype without neurofibromas [J]. Mol Genet Genomic Med, 2019, 7(5): e616. doi: 10.1002/mgg3.616. [12] Gutmann DH, Ferner RE, Listernick RH, et al. Neurofibromatosis type 1 [J]. Nat Rev Dis Primers, 2017, 3: 17004. doi: 10.1038/nrdp.2017.4. [13] Koczkowska M, Chen Y, Callens T, et al. Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 Codons 844-848 [J]. Am J Hum Genet, 2018, 102(1): 69-87. [14] Wilson BN, John AM, Handler MZ, et al. Neurofibromatosis type 1: New developments in genetics and treatment [J]. J Am Acad Dermatol, 2021, 84(6): 1667-1676. [15] Bayat M, Bayat A. Neurological manifestations of neurofibromatosis: a review [J]. Neurol Sci, 2020, 41(10): 2685-2690. [16] Hazan F, Gürsoy S, Unalp A, et al. Evaluation of clinical findings and neurofibromatosis type 1 bright objects on brain magnetic resonance images of 60 Turkish patients with NF1 gene variants [J]. Neurol Sci, 2021, 42(5): 2045-2057. [17] Lopes FFJ, Munis MP, Soares Souza A, et al. Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1 [J]. Pediatr Radiol, 2008, 38(3): 305-310. [18] Calvez S, Levy R, Calvez R, et al. Focal areas of high signal intensity in children with neurofibromatosis type 1: expected evolution on MRI [J]. AJNR Am J Neuroradiol, 2020, 41(9): 1733-1739. [19] Yao R, Yu T, Xu Y, et al. Clinical presentation and novel pathogenic variants among 68 Chinese neurofibromatosis 1 children [J]. Genes(Basel), 2019, 10(11): 847-855. [20] Rojnueangnit K, Xie J, Gomes A, et al. High incidence of noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: genotype-phenotype correlation [J]. Hum Mutat, 2015, 36(11): 1052-1063. [21] Sani I, Albanese A. Endocrine long-term follow-up of children with neurofibromatosis type 1 and optic pathway glioma [J]. Horm Res Paediatr, 2017, 87(3): 179-188. [22] Santoro C, Perrotta S, Picariello S, et al. Pretreatment endocrine disorders due to optic pathway gliomas in pediatric neurofibromatosis type 1: multicenter study [J]. J Clin Endocrinol Metab, 2020, 105(6): 1-8. [23] Gan HW, Phipps K, Aquilina K, et al. Neuroendocrine morbidity after pediatric optic gliomas: a longitudinal analysis of 166 children over 30 years [J]. J Clin Endocrinol Metab, 2015, 100(10): 3787-3799. [24] Sklar CA, Antal Z, Chemaitilly W, et al. Hypothalamic-pituitary and growth disorders in survivors of childhood cancer: an endocrine society clinical practice guideline [J]. J Clin Endocrinol Metab, 2018, 103(8): 2761-2784. [25] Pizzi WJ, EC Rode and JE Barnhart. Methylphenidate and growth: demonstration of a growth impairment and a growth-rebound phenomenon [J]. Dev Pharmacol Ther, 1986, 9(5): 361-368. [26] Vassilopoulou-Sellin R, Klein MJ, Slopis JK. Growth hormone deficiency in children with neurofibromatosis type 1 without suprasellar lesions [J]. Pediatr Neurol, 2000, 22(5): 355-358. [27] 张梅, 李艳英,班博, 等. 矮小症合并1型神经纤维瘤的诊断学特征及文献复习[J]. 中华诊断学电子杂志, 2014, 2(2): 30-31. ZHANG Mei, LI Yanying, BAN Bo, et al. Diagnostic features and review of the literature of dwarfism combined with neurofibroma 1 [J]. Chinese Journal of Diagnostics(Electronic Edition), 2014, 2(2): 30-31. [28] 韩慧侨, 潘慧, 王林杰, 等. 神经纤维瘤病1型并矮小症4例临床特点及文献复习[J]. 中华实用儿科临床杂志, 2019, 34(12): 946-949. HAN Huiqiao, PAN Hui, WANG Linjie, et al. Clinical features and literature review of 4 cases of neurofibromatosis type 1 with dwarfism [J]. Chinese Journal of Applied Clinical Pediatrics, 2019, 34(12): 946-949. [29] 潘丹萍, 陆相朋, 段凤阳, 等. 神经纤维瘤病Ⅰ型导致的3例身材矮小家系分析[J]. 中国儿童保健杂志, 2018, 26(4): 418-420. PAN Danping, LU Xiangpeng, DUAN Fengyang, et al. Pegidree analysis on three cases with short stature due to neurofibromatosis type I [J]. Chinese Journal of Child Health Care, 2018, 26(4): 418-420. [30] 龙晓丹, 熊静, 莫朝晖, 等. 生长激素缺乏合并1型神经纤维瘤病1例及其基因分析[J]. 中南大学学报(医学版), 2018, 43(7): 811-815. LONG Xiaodan, XIONG Jing, MO Zhaohui, et al. A case of growth hormone deficiency combined with neurofibromatosis type 1 and its gene analysis [J]. 2018, 43(7): 811-815. [31] Kang JH, Kim O, Kim J, et al. A novel mutation of exon 7 in growth hormone receptor mRNA in a patient with growth hormone insensitivity syndrome and neurofibromatosis type I [J]. Int J Mol Med, 2012, 30(3): 713-717. |
| [1] | CAO Ai-hua1, MA Liang2, YU Lin3, YANG Bing-shang1, ZHANG Xin-ting1, LEI Ge-fei1, WANG Ji-wen1. Effect of ABT-724 on ability of attentional set-shifting in spontaneously hypertensive rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(12): 15-19. |
| [2] | YUAN Chao1, ZHAO Jing-jie2, LIU Jun-li2, SHANG Wei1. ATP1A2 gene mutation detection in an alternating hemiplegia of childhood family [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(11): 79-. |
| [3] | KONG Min， GAO Yuxing. Effect of antiepileptic drugs on cognitive functions and expressions of glutamate receptor 2 and synaptophysin of the hippocampus in rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(7): 14-18. |
|
||
